Search Results

Displaying Results 1-1 of 1 "'ACET'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Lipocine Appoints Michael J. Grissinger to Board of Directors

Aug 03, 2026, 08:00 ET Lipocine Appoints Michael J. Grissinger to Board of Directors

companies, including Board Chair roles.  He currently serves on the board of directors at Aprea Therapeutics (Nasdaq: APRE) and Adicet Bio (Nasdaq: ACET). He also advises several privately-held biotech companies. Mr. Grissinger holds a B.S. in Chemistry from Juniata College and an M.B.A. from Temple University

More news about: Lipocine Inc.

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.